We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Brain Cancer

Journal Scan / Research · September 26, 2022

A Druggable Addiction to De Novo Pyrimidine Biosynthesis in Diffuse Midline Glioma

Cancer Cell


Additional Info

Cancer Cell
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma
Cancer Cell 2022 Sep 12;40(9)957-972.e10, S Pal, JP Kaplan, H Nguyen, SA Stopka, MR Savani, MS Regan, QD Nguyen, KL Jones, LA Moreau, J Peng, MG Dipiazza, AJ Perciaccante, X Zhu, BR Hunsel, KX Liu, S Alexandrescu, R Drissi, MG Filbin, SK McBrayer, NYR Agar, D Chowdhury, DA Haas-Kogan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading